Lotus Pharmaceutical Co., Ltd.

Lotus Pharmaceutical Co., Ltd.verified

1795.TW

Price:

$285.5

Market Cap:

$74.49B

Lotus Pharmaceutical Co., Ltd. research, develops, manufactures, and sells generic pharmaceutical products in Taiwan, Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system disease. The company also sells and markets a portfolio of over-the-counter medicines. In addition, it engages in wholesale of cosmetics; retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical; marketing activities; market planning and business information services; and consultancy services on health management, health ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2007-12-21

Stock Exchange

TAI

Ticker

1795.TW

The PE Ratio as of December 2025 (TTM) for Lotus Pharmaceutical Co., Ltd. (1795.TW) is 15.83

According to Lotus Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 15.83. This represents a change of 10.37% compared to the average of 14.34 of the last 4 quarters.

Lotus Pharmaceutical Co., Ltd. (1795.TW) Historical PE Ratio (quarterly & annually)

How has 1795.TW PE Ratio performed in the past?

The mean historical PE Ratio of Lotus Pharmaceutical Co., Ltd. over the last ten years is 195.32. The current 15.83 PE Ratio has changed 710.47% with respect to the historical average. Over the past ten years (40 quarters), 1795.TW's PE Ratio was at its highest in in the June 2016 quarter at 221.66. The PE Ratio was at its lowest in in the December 2017 quarter at -935.45.

Quarterly (TTM)
Annual

Average

195.32

Median

20.08

Minimum

-106.45

Maximum

1.58K

Lotus Pharmaceutical Co., Ltd. (1795.TW) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Lotus Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 19.69%

Maximum Annual PE Ratio = 1.58K

Minimum Annual Increase = -1587.95%

Minimum Annual PE Ratio = -106.45

Quarterly (TTM)
Annual
YearPE RatioChange
202413.93-20.51%
202317.53-17.40%
202221.2219.69%
202117.73-6.41%
202018.94-54.87%
201941.97-77.33%
2018185.10-88.31%
20171.58K-1587.95%
2016-106.45-166.81%
2015159.34-467.66%

Lotus Pharmaceutical Co., Ltd. (1795.TW) Average PE Ratio

How has 1795.TW PE Ratio performed in the past?

The current PE Ratio of Lotus Pharmaceutical Co., Ltd. (1795.TW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

17.56

5-year avg

17.87

10-year avg

195.32

Lotus Pharmaceutical Co., Ltd. (1795.TW) PE Ratio vs. Peers

How is 1795.TW’s PE Ratio compared to its peers?

Lotus Pharmaceutical Co., Ltd.’s PE Ratio is less than Bora Pharmaceuticals Co., Ltd. (19.24), less than YungShin Global Holding Corporation (15.97), greater than TTY Biopharm Company Limited (13.17), greater than Grape King Bio Ltd (15.47), less than Synmosa Biopharma Corporation (21.04), greater than Standard Chem & Pharm Co. Ltd. (12.01), less than TSH Biopharm Corporation Limited (17.69), less than Handa Pharmaceuticals, Inc. (23.11), less than SCI Pharmtech, Inc. (49.65), greater than Winston Medical Supply Co., Ltd. (12.00),

Build a custom stock screener for Lotus Pharmaceutical Co., Ltd. (1795.TW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lotus Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lotus Pharmaceutical Co., Ltd. (1795.TW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lotus Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Lotus Pharmaceutical Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Lotus Pharmaceutical Co., Ltd. (1795.TW)?

What is the highest PE Ratio for Lotus Pharmaceutical Co., Ltd. (1795.TW)?

What is the 3-year average PE Ratio for Lotus Pharmaceutical Co., Ltd. (1795.TW)?

What is the 5-year average PE Ratio for Lotus Pharmaceutical Co., Ltd. (1795.TW)?

How does the current PE Ratio for Lotus Pharmaceutical Co., Ltd. (1795.TW) compare to its historical average?